The major difference between GLP #1 and GLP #2 is that GLP #2 also acts as a GIP (glucose-dependent insulinotropic polypeptide)
When both can be considered together In some cases, a combination protocol is appropriate
Key Takeaways Your gut is the source of GLP-1
Impact of manganese on and transfer across blood-brain and blood-cerebrospinal fluid barrier in vitro
Potential side effects may include injection-site redness, swelling, bruising, itching, tenderness, small lumps, headache, fatigue, nausea, appetite changes, abdominal discomfort, stool changes, dizziness, altered sleep, mood changes, or feeling off. Allergic or immune reactions are also possible, and the FDA has specifically raised concerns about immunogenicity and peptide-related impurities in compounded BPC-157